Exelixis, Inc.

Exelixis, Inc.

Exelixis, Inc.

Overview
Date Founded

1994

Headquarters

210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080

Type of Company

Public

Employees (Worldwide)

773

Industries

Biotechnology
Hospitals & Patient Services
Pharmaceuticals

Company Description

Exelixis is a biopharmaceutical company committed to developing and commercializing small molecule therapies for the treatment of cancer. In advancing our first product, COMETRIQ, from discovery to market, we have established an effective and integrated infrastructure that encompasses the entire biopharmaceutical development continuum. We are committed to excellence in all aspects of our work and are dedicated to improving the care and outcome of cancer patients.

Website

http://www.exelixis.com

Contact Data
Trying to get in touch with decision makers at Exelixis, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
ENP Newswire
March 1, 2021
-Exelixis Partner Ipsen Receives Positive CHMP Opinion for CABOMETYX in Combination with OPDIVO as a First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
ENP Newswire
January 28, 2021
-Exelixis to Release Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 10, 2021
ENP Newswire
January 11, 2021
-Exelixis Announces Preliminary Fourth Quarter and Full Year 2020 Financial Results, Provides 2021 Financial Guidance, and Outlines Key Priorities and Anticipated Milestones For 2021
Business Wire
January 10, 2021
Exelixis Announces Preliminary Fourth Quarter and Full Year 2020 Financial Results, Provides 2021 Financial Guidance, and Outlines Key Priorities and Anticipated Milestones For 2021; - Cabozantinib Franchise Preliminary Net Product Revenue of $200 million
Business Wire
January 4, 2021
Exelixis to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021; - Presentation to be webcast on www.exelixis.com -

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Stelios Papadopoulos

Co-Founder

Michael Morrissey

President & Chief Executive Officer

Christopher Senner

Chief Financial Officer & Executive Vice President

Jeffrey J. Hessekiel

Executive Vice President & General Counsel

Peter Lamb

Executive Vice President, Scientific Strategy & Chief Scientific Officer

Gisela M. Schwab

President, Product Development & Medical Affairs & Chief Medical Officer

Laura Dillard

Executive Vice President-Human Resources

Susan T. Hubbard

Executive Vice President, Public Affairs & Investor Relations

P. J. Haley

Executive Vice President, Commercial

Dana Aftab

Executive Vice President, Business Operations

Board of Directors
Stelios Papadopoulos

Co-Founder at Exelixis, Inc.

Maria C. Freire

President & Executive Director at Foundation for the National Institutes of Health, Inc.

Alan M. Garber

Provost at Harvard University

George Poste

Vice Chairman at Inform Diagnostics, Inc.

Jack L. Wyszomierski

Former Executive Vice President & Chief Financial Officer at VWR International LLC

Carl B. Feldbaum

Founder at Biotechnology Innovation Organization

Lance Willsey

Former Founding Partner at DCF Capital LLC

Vincent T. Marchesi

Co-Founder at The American Academy of Anti-Aging Medicine, Inc.

Julie A. Smith

President & Chief Executive Officer at E-Scape Bio, Inc.

Michael Morrissey

President & Chief Executive Officer at Exelixis, Inc.

Trending People
H. C. Wainwright & Co. LLC
Daré Bioscience to Present at the H.C. Wainwright Global Life Sciences Conferenc... - GlobeNewswire
Dr. Seuss Enterprises LP
Six Dr. Seuss Books Will Stop Being Published Because of Racist Imagery - Time Magazine
Kohl's Corp.
Kohl's Should Reject Short-Sighted Activism - The Wall Street Journal
AB Volvo
How Green Are Electric Vehicles? - The New York Times
University of Illinois at Urbana-Champaign - College of Engineering
Intelligent.com Announces Best Graphic Design Degree Programs for 2021; Degree h... - PR Newswire
Trending Organizations
H. C. Wainwright & Co. LLC
Daré Bioscience to Present at the H.C. Wainwright Global Life Sciences Conferenc... - GlobeNewswire
Dr. Seuss Enterprises LP
Six Dr. Seuss Books Will Stop Being Published Because of Racist Imagery - Time Magazine
Kohl's Corp.
Kohl's Should Reject Short-Sighted Activism - The Wall Street Journal
AB Volvo
How Green Are Electric Vehicles? - The New York Times
University of Illinois at Urbana-Champaign - College of Engineering
Intelligent.com Announces Best Graphic Design Degree Programs for 2021; Degree h... - PR Newswire
Paths to Exelixis, Inc.
Potential Connections via
Relationship Science
You
Exelixis, Inc.
Owners & Shareholders
Details Hidden
Renaissance Technologies LLC

Renaissance Technologies LLC is an investment management company dedicated to producing superior returns for its clients and employees by adhering to mathematical and statistical methods.

Details Hidden
Meditor Capital Management Ltd.

MCM utilizes a bottom-up stock picking approach which is based on fundamental research and analysis. Their investment philosophy is based on the potential to add value through active management. The firm invests across market caps and believes that different companies need to be measured by different metrics. The investment managers conduct an extensive program of company visits complemented by external research from a network of consultants.

Details Hidden
Farallon Capital Management LLC

FCM seeks investments across asset classes and around the world through a process of bottom-up fundamental research and analysis emphasizing capital preservation. Their investment strategies include Credit Investments, Long/Short Equity, Merger Arbitrage, Risk Arbitrage, Real Estate Investments and Direct Investments. Investment ideas compete for capital based on in-depth, critical assessment of specific risks and rewards. Risk is monitored and managed through rigorous and thorough analysis of each investment and, at the portfolio level, through risk management analytics and overlay and tail-risk hedging.

Recent Transactions
Details Hidden

Exelixis, Inc. issued USD Common Stock

Details Hidden

Exelixis, Inc. issued USD Common Stock

Details Hidden

Exelixis, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Vincent T. Marchesi

Details Hidden
Peter Lamb

Details Hidden
Christopher Senner

Transaction Advisors
Underwriter
Cowen and Company LLC

Advised onExelixis, Inc. issued USD Common Stock

Underwriter
Goldman Sachs & Co. LLC

Advised onExelixis, Inc. issued USD Common Stock

Legal Advisor
Honigman Miller Schwartz and Cohn LLP

Advised onExelixis, Inc. issued USD Common Stock

Managing Director Head of Equity Capital Markets, Initial Public Offerings
Grant Miller

Advised onExelixis, Inc. issued USD Common Stock

Managing Director, ECM
Jason Fenten

Advised onExelixis, Inc. issued USD Common Stock

Corporate Officer
Deborah Marshall

Advised onExelixis, Inc. issued USD Common Stock
Advisors & Consultants
Legal Advisor
Robert Jones

Partner, Palo Alto at Cooley LLP

Legal Advisor
Chadwick Mills

Partner, San Francisco at Cooley LLP

Legal Advisor
Adriane M. Antler Ph.D.

Partner at Jones Day
Clients
CVS Health Corp.

CVS Health Corp. engages in the provision of health care services. It operates through the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioural health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

AmerisourceBergen Corporation

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company is headquartered in Chesterbrook, PA.

UnitedHealth Group, Inc.

UnitedHealth Group is a leading health care company, serving more than 75 million people worldwide. Our family of companies touches nearly every aspect of health care, helping people live healthier lives. We apply our capabilities broadly across health care in markets worldwide, providing health care management, consulting and specialty services globally. And we have the scale and resources necessary to take on some of the most important challenges in global health care. (www.unitedhealthgroup.com/global) As a leader in the health benefits and services industry, our six businesses — UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, OptumHealth, OptumInsight, and OptumRx — offer exceptional service, broad capabilities and enduring value in creating a modern health care system. Our products and services empower individuals, expand consumer choice and strengthen patient-provider relationships across the health care spectrum
Key Stats and Financials As of 2020
Market Capitalization
$6.84B
Total Enterprise Value
$4.56B
Earnings Per Share
$1.02
Revenue
$988M
Total Equity
$1.88B
Net Profit
$112M
EBITDAMargin
12.56%
Total Debt
$52.1M
EBITDA
$124M
Enterprise Value / Sales
5.29x
TEVNet Income
46.77x
Debt TEV
0.01x
Enterprise Value EBITDAOperating
41.73x
Three Year Compounded Annual Growth Rate Of Revenue
29.69%
Non-Profit Donations & Grants
$500 +
2019
Cancer Care, Inc.

$1,000 +
2019
University of Pittsburgh - Pittsburgh

$100K +
2018
American Liver Foundation

Investments
Details Hidden
Gentris Corp.

Gentris Corp. provides applied clinical phamacogenomic services. The company was founded on March 2001 and is headquartered in Morrisville, NC.

Investors
Details Hidden
Marvin H. Caruthers

Distinguished Professor of Chemistry & Biochemistry at The University of Colorado

Suppliers
Ceres, Inc. (California) Agriculture & Mills | Arden Hills, MN

Ceres, Inc. develops and markets seeds and traits to produce crops for feed, forages, sugar and other markets. It uses a combination of plant breeding, biotechnology and bioinformatics to develop seed products and biotechnology traits. The company was founded by Walter De Logi, Richard William Hamilton and Robert B. Goldberg in 1996 and is headquartered in Thousand Oaks, CA.

Ligand Pharmaceuticals, Inc. Medical Support Services | La Jolla, CA

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

Invenra, Inc. Medical Support Services | Madison, WI

Invenra, Inc. develops technology platform for biological drugs. It is a pre-clinical stage bio-pharmaceutical company focused on next-generation therapeutic human antibodies and antibody derivatives. The company was founded by Roland Greene and Emile F. Nuwaysir on July 24, 2014 and is headquartered Madison, WI.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Amgen, Inc. Biotechnology - Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Exelixis, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Exelixis, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Exelixis, Inc..